Jeremy Schafer and Deborah Lotterman discuss the impact that financial toxicity is having on patients and payers and outline the strategies pharma need to adopt to begin to remedy it.
Deborah Lotterman and Jeremy Schafer
Advertisement
Deborah Lotterman is Chief Creative Officer at precisioneffect. Jeremy Schafer, Pharm.D, MBA, is Senior Vice President at Precision for Value.
Articles by Deborah Lotterman and Jeremy Schafer
Advertisement
Latest Updated Articles
Financial Toxicity: Tracking a Growing Side EffectPublished: September 4th 2017 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER
3
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
4
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
5
